Stock RSPI RESPIRERX PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts RespireRx Pharmaceuticals Inc.

Equities

RSPI

US7612273059

Market Closed - OTC Markets
Other stock markets
 19:26:13 14/05/2024 BST 		5-day change 1st Jan Change
0.00096 USD +1.05% Intraday chart for RespireRx Pharmaceuticals Inc. +11.11% +11.11%
04-10 RespireRx Pharmaceuticals Inc. announced that it has received $0.1 million in funding CI
03-20 RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury CI

Chart: Technical Analysis

  1. Stock Market
  2. Equities
  3. RSPI Stock
  4. Charts RespireRx Pharmaceuticals Inc.